The recent small molecule anti-malarial patents review by the MMV teams is a very useful  job (http://www.citeulike.org/user/cdsouthan/article/11477246) and  the effort raises some questions.
 

This is a follow up to the post from May  
http://www.thesynapticleap.org/node/404
Unfortunately the vendors survery conducted on behalf of OSDD malaria, despite some helpfull publicity, came up with only two replies.
I have expounded on the possible reasons for failiure in this blog post
http://cdsouthan.blogspot.se/2012/07/shop-till-you-hit-part-ii.html

These announcments today refer to a new acess service for data on malaria-related compounds, assays and targets. This involves ChEMBL MMV and EBI.   Sounds good and I will take a look in due course
http://chembl.blogspot.se/2012/07/chembl-delivers-new-malaria-data.html?...
http://www.ebi.ac.uk/Information/News/press-releases/press-release-13072...

I have been helping out with public searches for the OSM-S compounds.  One of the many utilities of PubChem is as a meta-vendor portal.  The question immediately arises as to what analogs of the more potent hits might be available for purchase and testing via the outlinks provided in PubChem.  I consider myself  able and willing to navigate the bioactivity spaghetti links but this is the first time I have done any serious ferreting through the vendor maze.  Because this turned out to be unexpectedly difficult I have written a personal blog post  that I hope will be informative for the proje